Breast Cancer Clinical Trial

A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)

Summary

The purpose of this study is to look at how differences in cognitive (mental) function develop over time in breast cancer survivors compared to volunteers without a history of cancer (healthy volunteers). Both cancer survivors and healthy volunteers (who are the same age as the cancer survivors) will participate in this study so the researchers can compare the results of neurocognitive testing (which looks at memory, attention, and information processing) on each group of participants.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

All Participants:

Per medical record and/or self-report, identifies as female
Per medical record and/or self-report, currently age 65-80
Per self-report, has access to a computer and internet connectivity
Score of <11 on Blessed Orientation-Memory-Concentration Test (BOMC)
As per medical record or self-report, if currently taking psychoactive medications (including but not limited to antidepressants and anxiolytics), dose must have been stable at least two months prior to enrollment.
English fluent (as per self-report, fluency of "well" or "very well", and having a reasonable comprehension of the study conversation in the opinion of the research staff)**

Breast Cancer Survivors:

Per medical record and/or self-report, history of stage 1-3 breast cancer diagnosed between 55-60 years of age
Per medical record and/or self-report, no evidence of disease (NED)

Non-Cancer Controls:

Per self-report, no history of breast cancer

Language verification: For both survivors and controls, prior to enrollment, all will be asked the following two questions by a CRC to verify English fluency necessary for participation in the study:

How well do you speak English? (must respond "Well" or "Very well" when given the choices of Very well, Well, Not well, Not at all, Don't know, or Refused)
What is your preferred language for healthcare? (must respond English)

Exclusion Criteria:

All participants:

As per medical record or self-report, diagnosis of neurodegenerative disorder that affects cognitive function (e.g. Alzheimer's disease, Parkinson's disease, Multiple Sclerosis, Dementia, Seizure Disorders, etc.)
As per medical record or self-report, history of stroke or head injury with loss of consciousness for 30+ minutes or more
As per medical record or self-report, a diagnosis of a major Axis I psychiatric disorder including Schizophrenia Spectrum Disorder, substance use disorder, Bipolar Disorder or Schizotypal personality disorder. Schizophrenia Spectrum Disorders include Schizophrenia, Schizophreniform disorder, Schizoaffective disorder, Delusional disorder, Brief psychotic disorder, and Attenuated Psychotic Disorder.
As per medical record or self-report, visual or auditory impairment that would preclude ability to complete the assessments (e.g. history of significant macular degeneration or being unable to correct hearing with hearing aids)
As per medical record or self-report, use of methotrexate (Amethopterin, Rhematrex, Trexall) or rituximab (Rituxin) for rheumatoid arthritis, psoriasis or Crohn's disease, or cyclophosphamide (Cytoxan, Neosar) for lupus.
As per medical record or self-report, participation in a conflicting (overlapping neurocognitive assessments) research study (i.e. MSK 18-294)

Breast Cancer Survivors:

As per medical record or self-report, any history of cancer except non-melanoma skin cancer or breast cancer

Non-Cancer Controls:

As per medical record or self-report, history of treatment using radiation, chemotherapy, and/or Tamoxifen or Aromatase-inhibitors
As per medical record or self-report, any history of cancer except non-melanoma skin cancer

Study is for people with:

Breast Cancer

Estimated Enrollment:

420

Study ID:

NCT06334354

Recruitment Status:

Recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 7 Locations for this study

See Locations Near You

Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Basking Ridge New Jersey, 07920, United States More Info
James Root, PhD
Contact
646-888-0035
Memorial Sloan Kettering Monmouth (All protocol activities)
Middletown New Jersey, 07748, United States More Info
James Root, PhD
Contact
646-888-0035
Memorial Sloan Kettering Bergen (All Protocol Activities)
Montvale New Jersey, 07645, United States More Info
James Root, PhD
Contact
646-888-0035
Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities)
Commack New York, 11725, United States More Info
James Root, PhD
Contact
646-888-0035
Memorial Sloan Kettering Westchester (All Protocol Activities)
Harrison New York, 10604, United States More Info
James Root, PhD
Contact
646-888-0035
Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States More Info
James Root, PhD
Contact
646-888-0035
Tim Ahles, PhD
Contact
646-888-0048
James Root, PhD
Principal Investigator
Memorial Sloan Kettering Nassau (All Protocol Activities)
Uniondale New York, 11553, United States More Info
James Root, PhD
Contact
646-888-0035

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

420

Study ID:

NCT06334354

Recruitment Status:

Recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.